Azithromycin in the treatment of mucosal Leishmaniasis

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 46, Issue 3, 2004, Pages 175-177

  Silva Vergara, Mario León ^a   Silva, Luciana De Almeida ^a   Maneira, Frederico Ricardo Zago ^a   Da Silva, Achilles Gustavo ^a   Prata, Aluízio ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

Azithromycin; Chronic cardiopathy; Mucosal leishmaniasis

Indexed keywords

AZITHROMYCIN; MEGLUMINE ANTIMONATE; NIFURTIMOX; STIBOGLUCONATE SODIUM;

AGED; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG MECHANISM; HEART DISEASE; HUMAN; LEISHMANIA; LEISHMANIASIS; MALE;

EID: 3142659091     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-46652004000300011     Document Type: Article

References (20)

1. BERMAN, J.D. - Human leishmaniasis: clinical diagnostic and chemotherapeutic developments in the last 10 years. Clin. infect. Dis., 24: 684-703, 1997.
2. BRASIL. MINISTÉRIO DA SAÚDE. FUNDAÇAO NACIONAL DA SAÚDE - Manual de controle da leishmaniose tegumentar american. Brasília, FNS, 2000.
3. FRANKE, E.D.; LLANOS CUENTAS, A.; ECHEVARRIA, J. et al. - Efficacy of 28-day and 40-day regimens of sodium stibogluconate (pentostam) in the treatment of mucosal leishmaniasis. Amer. J. trop. Med. Hyg., 51: 77-82, 1994.
4. GUERRA, M.F.; MARSDEN, P.D.; CUBA, C.C. & BARRETTO, A.C. - Further trials of nifurtimox in mucocutaneous leishmaniasis. Trans. roy. Soc. trop. Med. Hyg., 75: 335-337, 1981.
5. HERWALDT, B. & BERMAN, J.D. - Recommendations for treating leishmaniasis with sodium stibogluconate (pentostam) and review of pertinent clinical studies. Amer. J. trop. Med. Hyg., 46: 296-306, 1992.
6. KROLEWIECKI, A.J.; LEON, S.; SCOTT, P. & ABRAHAM, D. - Activity of azithromycin against Leishmania major in vitro and in vivo Amer. J. trop. Med. Hyg., 67: 273-277, 2002.
7. LESSA, H.A.; MACHADO, P.; LIMA, F. et al. - Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Amer. J. trop. Med. Hyg., 65: 87-89, 2001.
8. MARSDEN, P.D. - Mucosal leishmaniasis ("Espundia" Escomel 1911). Trans. roy. Soc. trop. Med. Hyg., 80: 859-876, 1986.
9. MARSDEN, P.D. - Mucosal leishmaniasis due to Leishmania (Viannia) braziliensis L(V)b in Três Braços, Bahia, Brazil. Rev. Soc. bras. Med. trop. 27: 93-101, 1994.
10. NEU, H.C. - Clinical microbiology of azithromycin. Amer. J. Med., 91(suppl. 3A): 12S-18S, 1991.
11. OLLIARO, P.L. & BRYCESON, A.D.M. - Practrical progress and new drugs for changing patterns of leishmaniasis. Parasit. today, 9: 323-328, 1993.
12. PETERS, D.H.; FRIEDEL, H.A. & McTAVISH, D. - Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs, 44: 750-799, 1992.
13. PRATA, A.; SILVA-VERGARA, M.L.; COSTA, L. et al. - Efficacy of azithromycin in the treatment of cutaneous leishmaniasis. Rev. Soc. bras. Med. trop., 36: 65-69, 2003.
14. SAMPAIO, S.A.P.; GODOY, J.T.; PAIVA, L.; DILLON, N.L. & LACAZ, C.S. - The treatment of American (mucocutaneous) leishmaniasis with amphotericin B. Arch. Derm., 82: 627-635, 1960.
15. SAMPAIO, R.N.R. & MARSDEN, P.D. - Tratamento da forma mucosa da leishmaniose sem resposta a glucantime com anfotericina B lipossomal. Rev. Soc. bras. Med. trop., 30: 125-128, 1997.
16. SOTO-MANCIPE, J.; GROGL, M. & BERMAN, J. - Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia. Clin. infect. Dis., 16: 417-425, 1993.
17. TEIXEIRA, A.C. - Avaliação da eficácia da azitromicina no tratamento da leishmaniose cutãnea em Manaus, Amazonas, Brasil. Uberaba, 2003. (Dissertaçao de Mestrado - Ficuldade de Medicina do Triãngulo Mineiro).
18. WHO (WORLD HEALTH ORGANIZATION)/OPS (ORGANIZACIÓN PANAMERICANA DE LA SALUD - Leishmaniasis en las Américas. Situación actual y alternativas para su control. Washington, Oficina Sanitária Panamericana, Oficina Regional de la Organización Mundial de la Salud, 1996.
19. WILDFLEUER, A.; LAUFEN, H. & ZIMMERMANN, T. - Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions. Antimicrob. Agents Chemother., 40: 75-79, 1996.
20. YARDLEY, Y. & CROFT, S.L. - A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis. Int. J. Antimicrob. Agents, 13: 243-248, 2000.